Aya Miyaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aya Miyaki has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth R. Lawlor
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute
32 shared publications - Emma D. Wrenn
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute
32 shared publications - April A. Apfelbaum
Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute
31 shared publications - Nicolas M. Garcia
Ben Towne Center for Childhood Cancer & Blood Disorders Research, Seattle Children’s Research Institute, Seattle, WA, USA
31 shared publications - Erika A. Newman
University of Michigan, C.S. Mott Children’s Hospital, Section of Pediatric Surgery, Ann Arbor, MI
30 shared publications - Erin R. Rudzinski
Department of Laboratories Seattle Children's Hospital Seattle Washington USA
30 shared publications
Latest Publications
- Open Access
- 23 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (4) , eady0550
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma
Subpopulations of cancer-associated fibroblast (CAF)–like tumor cells deposit extracellular matrix (ECM) proteins that support Ewing sarcoma (EwS) progression and metastasis. We previously showed a hallmark of CAF-like EwS cells is their hybrid transcriptional state wherein the driver fusion oncogene, EWS::FLI1, maintains activation of proliferative programs but loses capacity to repress mesenchymal genes. Here, we studied primary patient tumors and cell line models to identify molecular drivers of this hybrid state. Our data reveal that hybrid EwS cells are induced and maintained by a transforming growth factor–β (TGFβ) signaling positive feedback loop. Hybrid cells derepress TGFBR2 and up-regulate expression and secretion of TGFβ2 to sustain pathway activation and ECM deposition. Although TGFβ ligands can potently induce growth arrest in cells of epithelial origin, we show that TGFβ1 and TGFβ2 promote cell invasion of EwS cells without affecting proliferation. Thus, stroma-derived and tumor-derived TGFβ ligands induce and maintain hybrid EwS cells to promote pro-metastatic cell phenotypes.
- 23 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (4) , eady0550
Open AccessAutocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma
Subpopulations of cancer-associated fibroblast (CAF)–like tumor cells deposit extracellular matrix (ECM) proteins that support Ewing sarcoma (EwS) progression and metastasis. We previously showed a hallmark of CAF-like EwS cells is their hybrid transcriptional state wherein the driver fusion oncogene, EWS::FLI1, maintains activation of proliferative programs but loses capacity to repress mesenchymal genes. Here, we studied primary patient tumors and cell line models to identify molecular drivers of this hybrid state. Our data reveal that hybrid EwS cells are induced and maintained by a transforming growth factor–β (TGFβ) signaling positive feedback loop. Hybrid cells derepress TGFBR2 and up-regulate expression and secretion of TGFβ2 to sustain pathway activation and ECM deposition. Although TGFβ ligands can potently induce growth arrest in cells of epithelial origin, we show that TGFβ1 and TGFβ2 promote cell invasion of EwS cells without affecting proliferation. Thus, stroma-derived and tumor-derived TGFβ ligands induce and maintain hybrid EwS cells to promote pro-metastatic cell phenotypes.
- Open Access
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma
Sub-populations of cancer-associated fibroblast (CAF)-like tumor cells deposit extracellular matrix (ECM) proteins that support Ewing sarcoma (EwS) progression and metastasis. We previously showed a hallmark of CAF-like EwS cells is their hybrid transcriptional state wherein the driver fusion oncogene, EWS::FLI1, maintains activation of proliferative programs but loses capacity to repress mesenchymal genes. Here, we studied primary patient tumors and cell line models to identify molecular drivers of this hybrid state. Our data reveal that hybrid EwS cells are induced and maintained by a TGFβ signaling positive feedback loop. Hybrid cells de-repress TGFBR2 and upregulate expression and secretion of TGFβ2 to sustain pathway activation and ECM deposition. While TGFβ ligands can potently induce growth arrest in cells of epithelial origin, we show that TGFβ1 and TGFβ2 promote cell invasion of EwS cells without affecting proliferation. Thus, stroma and tumor-derived TGFβ ligands induce and maintain hybrid EwS cells to promote pro-metastatic cell phenotypes.
Open AccessAutocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma
Sub-populations of cancer-associated fibroblast (CAF)-like tumor cells deposit extracellular matrix (ECM) proteins that support Ewing sarcoma (EwS) progression and metastasis. We previously showed a hallmark of CAF-like EwS cells is their hybrid transcriptional state wherein the driver fusion oncogene, EWS::FLI1, maintains activation of proliferative programs but loses capacity to repress mesenchymal genes. Here, we studied primary patient tumors and cell line models to identify molecular drivers of this hybrid state. Our data reveal that hybrid EwS cells are induced and maintained by a TGFβ signaling positive feedback loop. Hybrid cells de-repress TGFBR2 and upregulate expression and secretion of TGFβ2 to sustain pathway activation and ECM deposition. While TGFβ ligands can potently induce growth arrest in cells of epithelial origin, we show that TGFβ1 and TGFβ2 promote cell invasion of EwS cells without affecting proliferation. Thus, stroma and tumor-derived TGFβ ligands induce and maintain hybrid EwS cells to promote pro-metastatic cell phenotypes.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 3 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 3. RNAseq-derived gene expression data for CD73- and CD73+ A673 and CHLA10 cells.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 3 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 3. RNAseq-derived gene expression data for CD73- and CD73+ A673 and CHLA10 cells.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S2 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Figure S2. CD73+ cells are enriched in EMT and ECM gene expression. Related to Figure 2.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S2 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Figure S2. CD73+ cells are enriched in EMT and ECM gene expression. Related to Figure 2.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 4. Top 200 markers of NT5E+ cells (by fold change vs. NT5E- cells) from nine EwS cell lines by single cell sequencing.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 4. Top 200 markers of NT5E+ cells (by fold change vs. NT5E- cells) from nine EwS cell lines by single cell sequencing.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 1. Table of selected reagents and resources used.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 1. Table of selected reagents and resources used.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S5 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Figure S5. Patient tumor gene expression microarrays display heterogeneity of expression of NT5E and associated mesenchymal gene signature. Related to Figure 5.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S5 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Figure S5. Patient tumor gene expression microarrays display heterogeneity of expression of NT5E and associated mesenchymal gene signature. Related to Figure 5.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S3 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Figure S3. Spatial heterogeneity of CD73+ tumor cells and ECM deposition in additional xenograft and PDX-derived models. Related to Figure 3.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S3 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Figure S3. Spatial heterogeneity of CD73+ tumor cells and ECM deposition in additional xenograft and PDX-derived models. Related to Figure 3.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 2. 52 genes overlapping between markers of cells with high GO:BP Mesenchymal Development from A673 and CHLA10 single cell sequencing and EWS::FLI1 repressed gene set.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 2. 52 genes overlapping between markers of cells with high GO:BP Mesenchymal Development from A673 and CHLA10 single cell sequencing and EWS::FLI1 repressed gene set.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 7. Clinical information and CD73 IHC score for patient tumor tissue microarray.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Supplemental Table 7. Clinical information and CD73 IHC score for patient tumor tissue microarray.